AI assistant
Sending…
Cellectar Biosciences, Inc. — Director's Dealing 2020
Dec 28, 2020
35021_dirs_2020-12-28_63d350cc-bb6f-4aaf-b37f-fd553d233407.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2020-12-28
Reporting Person: Elefant Dov (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-12-28 | Common Stock | P | 7407 | $1.35 | Acquired | 11755 | Direct |
More from Cellectar Biosciences, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jul 10
Regulatory Filings
2026
Jun 2
Regulatory Filings
2026
May 29
Proxy Solicitation & Information Statement
2026
May 28
Proxy Solicitation & Information Statement
2026
May 28
Regulatory Filings
2026
May 19
Board/Management Information
2026
May 18
Earnings Release
2026
May 14
Interim / Quarterly Report
2026
May 14
Capital/Financing Update
2026
May 8